{
    "nct_id": "NCT06425302",
    "official_title": "A Phase 2 Randomized, Open Label Study to Evaluate the Efficacy and Safety of Golcadomide in Combination With Rituximab in Participants With Newly Diagnosed Advanced Stage Follicular Lymphoma",
    "inclusion_criteria": "Inclusion Criteria\n\n* Participant has histologically confirmed Grade 1, 2 or 3a follicular lymphoma (FL) or classic FL. Formalin-fixed paraffin embedded (FFPE) archival tissue from 1 year prior to screening is allowed. If more than 1 year has passed, then a fresh biopsy must be obtained to confirm the diagnosis.\n* Have no prior systemic treatment for follicular lymphoma. Prior radiation therapy or surgery for previously diagnosed stage I disease is acceptable.\n* Stage II to IV disease.\n* Deemed to need treatment by treating investigator. Reasons for treatment can include, but are not limited to, the following:.\n\n  i) Bulky disease defined as:.\n\nA. A nodal or extra nodal (except spleen) mass > 7cm in its greater diameter or, involvement of at least 3 nodal or extra nodal sites (each with a diameter greater than >3 cm).\n\nii) Presence of at least one of the following B symptoms:.\n\nA. Fever (>38Â°C) of unclear etiology.\n\nB. Night sweats.\n\nC. Weight loss greater than 10% within the prior 6 months.\n\niii) Splenomegaly with inferior margin below the umbilical line.\n\niv) Any one of the following cytopenia due to lymphoma:.\n\nA. Platelets <100,000 cells/mm3 (100 x 109/L).\n\nB. Absolute neutrophil count (ANC) < 1,000 cells/mm3 (1.0 x 109/L).\n\nC. Hemoglobin < 10g/dL (6.25 mmol/L).\n\nv) Pleural or peritoneal serous effusion (irrespective of cell content).\n\nvi) Any compressive syndrome (for example, but not restricted to ureteral, orbital, gastrointestinal).\n\nExclusion Criteria\n\n* Clinical evidence of transformed lymphoma by investigator assessment.\n* Follicular Large Cell as per WHO 5th classification or Grade 3b follicular lymphoma as per WHO 4th classification.\n* Participant has any significant medical condition, active infection, laboratory abnormality, or psychiatric illness that would prevent the participation in the study.\n* Other protocol-defined Inclusion/Exclusion criteria apply.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "",
    "miscellaneous_criteria": ""
}